Willis Towers Watson Public Limited Co (WTW) concluded trading on Thursday at a closing price of $306.64, with 0.43 million shares of worth about $130.66 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.11% during that period and on July 03, 2025 the price saw a gain of about 0.72%. Currently the company’s common shares owned by public are about 99.21M shares, out of which, 98.71M shares are available for trading.
Stock saw a price change of 1.60% in past 5 days and over the past one month there was a price change of -2.28%. Year-to-date (YTD), WTW shares are showing a performance of 18.20% which decreased to -2.11% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $255.19 but also hit the highest price of $344.14 during that period. The average intraday trading volume for Willis Towers Watson Public Limited Co shares is 709.57K.
Willis Towers Watson Public Limited Co (NASDAQ: WTW) currently have 99.21M outstanding shares and institutions hold larger chunk of about 95.19% of that.
The stock has a current market capitalization of $30.40B and its 3Y-monthly beta is at 0.68. It has posted earnings per share of -$0.51 in the same period. It has Quick Ratio of 1.16 while making debt-to-equity ratio of 0.73. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for WTW, volatility over the week remained 1.62% while standing at 1.73% over the month.
Stock’s fiscal year EPS is expected to drop by -1.61% while it is estimated to increase by 14.10% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on March 18, 2025 offering a Buy rating for the stock and assigned a target price range of between $344 and $395 to it. Coverage by Evercore ISI stated Willis Towers Watson Public Limited Co (WTW) stock as an Outperform in their note to investors on January 08, 2025, suggesting a price target of $373 for the stock. On December 20, 2024, Jefferies Upgrade their recommendations, while on December 05, 2024, Raymond James Upgrade their ratings for the stock with a price target of $400. Stock get an Underweight rating from Barclays on September 05, 2024.
